179 related articles for article (PubMed ID: 31215992)
1. Activator of G protein signaling 3 modulates prostate tumor development and progression.
Adekoya TO; Smith N; Aladeniyi T; Blumer JB; Chen XL; Richardson RM
Carcinogenesis; 2019 Dec; 40(12):1504-1513. PubMed ID: 31215992
[TBL] [Abstract][Full Text] [Related]
2. Host versus cell-dependent effects of β-arrestin 1 expression in prostate tumorigenesis.
Adekoya TO; Smith N; Thomas AJ; Lane TS; Burnette N; Rivers EJ; Li Y; Chen XL; Richardson RM
Carcinogenesis; 2021 May; 42(5):772-783. PubMed ID: 33710266
[TBL] [Abstract][Full Text] [Related]
3. Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP).
da Silva RF; Nogueira-Pangrazi E; Kido LA; Montico F; Arana S; Kumar D; Raina K; Agarwal R; Cagnon VHA
J Biomed Sci; 2017 May; 24(1):31. PubMed ID: 28499383
[TBL] [Abstract][Full Text] [Related]
4. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
[TBL] [Abstract][Full Text] [Related]
5. P21 and P27 promote tumorigenesis and progression via cell cycle acceleration in seminal vesicles of TRAMP mice.
Li T; Wang F; Dang Y; Dong J; Zhang Y; Zhang C; Liu P; Gao Y; Wang X; Yang S; Lu S
Int J Biol Sci; 2019; 15(10):2198-2210. PubMed ID: 31592235
[TBL] [Abstract][Full Text] [Related]
6. Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer.
Jeet V; Ow K; Doherty E; Curley B; Russell PJ; Khatri A
Prostate; 2008 Apr; 68(5):548-62. PubMed ID: 18247402
[TBL] [Abstract][Full Text] [Related]
7. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
Pulukuri SM; Rao JS
Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
[TBL] [Abstract][Full Text] [Related]
8. The secreted matrix protein mindin increases prostate tumor progression and tumor-bone crosstalk via ERK 1/2 regulation.
Ardura JA; Gutiérrez-Rojas I; Álvarez-Carrión L; Rodríguez-Ramos MR; Pozuelo JM; Alonso V
Carcinogenesis; 2019 Jul; 40(7):828-839. PubMed ID: 31168562
[TBL] [Abstract][Full Text] [Related]
9. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
10. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.
Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M
Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404
[TBL] [Abstract][Full Text] [Related]
11. Translocation of activator of G-protein signaling 3 to the Golgi apparatus in response to receptor activation and its effect on the trans-Golgi network.
Oner SS; Vural A; Lanier SM
J Biol Chem; 2013 Aug; 288(33):24091-103. PubMed ID: 23770668
[TBL] [Abstract][Full Text] [Related]
12. Interaction of activator of G-protein signaling 3 (AGS3) with LKB1, a serine/threonine kinase involved in cell polarity and cell cycle progression: phosphorylation of the G-protein regulatory (GPR) motif as a regulatory mechanism for the interaction of GPR motifs with Gi alpha.
Blumer JB; Bernard ML; Peterson YK; Nezu J; Chung P; Dunican DJ; Knoblich JA; Lanier SM
J Biol Chem; 2003 Jun; 278(26):23217-20. PubMed ID: 12719437
[TBL] [Abstract][Full Text] [Related]
13. Defective chemokine signal integration in leukocytes lacking activator of G protein signaling 3 (AGS3).
Branham-O'Connor M; Robichaux WG; Zhang XK; Cho H; Kehrl JH; Lanier SM; Blumer JB
J Biol Chem; 2014 Apr; 289(15):10738-10747. PubMed ID: 24573680
[TBL] [Abstract][Full Text] [Related]
14. Role of G-proteins and phosphorylation in the distribution of AGS3 to cell puncta.
Vural A; Fadillioglu E; Kelesoglu F; Ma D; Lanier SM
J Cell Sci; 2018 Dec; 131(23):. PubMed ID: 30404823
[TBL] [Abstract][Full Text] [Related]
15. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.
Escara-Wilke J; Keller JM; Ignatoski KM; Dai J; Shelley G; Mizokami A; Zhang J; Yeung ML; Yeung KC; Keller ET
Prostate; 2015 Feb; 75(3):292-302. PubMed ID: 25327941
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of activator of G-protein signaling 3 decreases the proliferation of esophageal squamous cell carcinoma.
Shi H; Ren H; Yang X; Zhu H; Yao L; Hang Q; Mao H; Huang Y; Zhang J; Wang Y
Pathol Res Pract; 2015 Jun; 211(6):449-55. PubMed ID: 25812748
[TBL] [Abstract][Full Text] [Related]
17. GDI2 is a target of paclitaxel that affects tumorigenesis of prostate cancer via the p75NTR signaling pathway.
Liu C; Wang W; Lin P; Xie H; Jiang S; Jia H; Li R; Wang N; Yu X
Biochem Biophys Res Commun; 2021 Jul; 562():119-126. PubMed ID: 34051575
[TBL] [Abstract][Full Text] [Related]
18. IGFBP3 and MAPK/ERK signaling mediates melatonin-induced antitumor activity in prostate cancer.
Mayo JC; Hevia D; Quiros-Gonzalez I; Rodriguez-Garcia A; Gonzalez-Menendez P; Cepas V; Gonzalez-Pola I; Sainz RM
J Pineal Res; 2017 Jan; 62(1):. PubMed ID: 27736013
[TBL] [Abstract][Full Text] [Related]
19. Genistein alters growth factor signaling in transgenic prostate model (TRAMP).
Wang J; Eltoum IE; Lamartiniere CA
Mol Cell Endocrinol; 2004 Apr; 219(1-2):171-80. PubMed ID: 15149738
[TBL] [Abstract][Full Text] [Related]
20. Genetic ablation of the amplified-in-breast cancer 1 inhibits spontaneous prostate cancer progression in mice.
Chung AC; Zhou S; Liao L; Tien JC; Greenberg NM; Xu J
Cancer Res; 2007 Jun; 67(12):5965-75. PubMed ID: 17575167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
